• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强效吗啉基蒽环类药物。

Intensely potent morpholinyl anthracyclines.

作者信息

Acton E M, Tong G L, Mosher C W, Wolgemuth R L

出版信息

J Med Chem. 1984 May;27(5):638-45. doi: 10.1021/jm00371a014.

DOI:10.1021/jm00371a014
PMID:6716401
Abstract

3'-Deamino-3'-(3-cyano-4-morpholinyl)doxorubicin is a new analogue that is 100 to 1000 times more potent than doxorubicin against tumors in cell culture or in mice, that is active by intraperitoneal, intravenous, or oral dosing, and that does not produce chronic myocardial lesions in mice. This analogue was encountered in studies on the reductive alkylation of doxorubicin and daunorubicin with 2,2' - oxybis [acetaldehyde], which constructs a morpholino ring incorporating the amino N. The morpholinyl nitrile byproducts are separated by virtue of their nonbasicity from the expected morpholino derivatives. The 13-dihydro and 5-imino derivatives are also described in this important new class of anthracyclines.

摘要

3'-脱氨基-3'-(3-氰基-4-吗啉基)阿霉素是一种新的类似物,在细胞培养或小鼠体内对肿瘤的效力比阿霉素强100至1000倍,可通过腹腔注射、静脉注射或口服给药,且在小鼠体内不会产生慢性心肌损伤。这种类似物是在对阿霉素和柔红霉素与2,2'-氧双[乙醛]进行还原烷基化的研究中发现的,该反应构建了一个包含氨基N的吗啉环。吗啉基腈副产物因其非碱性而与预期的吗啉基衍生物分离。本文还描述了这一重要的新型蒽环类化合物中的13-二氢和5-亚氨基衍生物。

相似文献

1
Intensely potent morpholinyl anthracyclines.强效吗啉基蒽环类药物。
J Med Chem. 1984 May;27(5):638-45. doi: 10.1021/jm00371a014.
2
New cyanomorpholinyl byproduct of doxorubicin reductive alkylation.阿霉素还原烷基化反应产生的新型氰基吗啉基副产物。
J Med Chem. 1986 Jul;29(7):1225-30. doi: 10.1021/jm00157a019.
3
Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.柔红霉素、5-亚氨基柔红霉素和阿霉素的N-烯胺衍生物的合成及其抗白血病活性
J Antibiot (Tokyo). 1988 Feb;41(2):193-8. doi: 10.7164/antibiotics.41.193.
4
Synthesis and antitumor activity of novel 4-demethoxyanthracyclines.
J Med Chem. 1990 Sep;33(9):2375-9. doi: 10.1021/jm00171a010.
5
Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin.
J Med Chem. 1982 Jan;25(1):18-24. doi: 10.1021/jm00343a004.
6
Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.抗肿瘤活性的7 - O -(2,6 - 二脱氧 - 2 - 氟 -α - L - 塔罗吡喃糖基)柔红霉素酮和阿霉素酮的合成。
Carbohydr Res. 1987 Nov 15;169:69-81. doi: 10.1016/0008-6215(87)80243-4.
7
N-salicylidene derivatives of pirarubicin.
J Antibiot (Tokyo). 1989 Jul;42(7):1133-44. doi: 10.7164/antibiotics.42.1133.
8
[Models of preclinical studies of anthracyclines].[蒽环类药物的临床前研究模型]
Pathol Biol (Paris). 1987 Jan;35(1):41-8.
9
Improved antitumor effects of 3'-deamino-3'-morpholino derivatives of pirarubicin.
J Antibiot (Tokyo). 1990 Nov;43(11):1464-70. doi: 10.7164/antibiotics.43.1464.
10
Antitumor activity of new morpholino anthracyclines.
J Antibiot (Tokyo). 1988 Apr;41(4):548-53. doi: 10.7164/antibiotics.41.548.

引用本文的文献

1
Heterocycles via intramolecular platinum-catalyzed propargylic substitution.通过分子内铂催化的炔丙基取代反应合成杂环化合物。
Tetrahedron. 2011 Jul 8;67(27-28):5046-5053. doi: 10.1016/j.tet.2011.03.115.
2
A prolonged methoxymorpholino doxorubicin (PNU-152243 or MMRDX) infusion schedule in patients with solid tumours: a phase 1 and pharmacokinetic study.实体瘤患者中延长甲氧基吗啉代阿霉素(PNU - 152243或MMRDX)输注方案:一项1期和药代动力学研究。
Br J Cancer. 2000 Feb;82(4):767-71. doi: 10.1054/bjoc.1999.0996.
3
Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patients.
甲氧基吗啉代阿霉素(FCE 23762-MMRDX)在非小细胞肺癌、肾癌及其他实体瘤患者中的广泛II期和药代动力学研究。
Br J Cancer. 1998;77(1):139-46. doi: 10.1038/bjc.1998.22.
4
High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin.阿霉素高效转化为2-吡咯啉阿霉素,一种活性强500 - 1000倍的类似物:柔红霉素修饰的阿霉素衍生物的构效关系
Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2464-9. doi: 10.1073/pnas.93.6.2464.
5
Organ distribution and tumor uptake of annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesicles.多泡囊包裹的新型对脂质膜具有高亲和力的蒽环类衍生物阿霉素的器官分布和肿瘤摄取情况。
Cancer Chemother Pharmacol. 1993;32(3):190-6. doi: 10.1007/BF00685834.
6
Thermal stability of DNA adducts induced by cyanomorpholinoadriamycin in vitro.体外氰基吗啉代阿霉素诱导的DNA加合物的热稳定性
Nucleic Acids Res. 1993 Apr 25;21(8):1857-62. doi: 10.1093/nar/21.8.1857.
7
Effects of the methoxymorpholino derivative of doxorubicin and its bioactivated form versus doxorubicin on human leukemia and lymphoma cell lines and normal bone marrow.
Cancer Chemother Pharmacol. 1993;33(1):10-6. doi: 10.1007/BF00686016.
8
Cellular pharmacology of the partially non-cross-resistant anthracycline annamycin entrapped in liposomes in KB and KB-V1 cells.包裹于脂质体中的部分非交叉耐药蒽环类抗生素阿霉素在KB和KB-V1细胞中的细胞药理学
Cancer Chemother Pharmacol. 1994;34(2):109-18. doi: 10.1007/BF00685927.
9
Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin.重组转化生长因子β1和β2可保护小鼠免受致死剂量的5-氟尿嘧啶和阿霉素的急性毒性作用。
J Exp Med. 1994 Sep 1;180(3):1047-57. doi: 10.1084/jem.180.3.1047.
10
Growth-inhibitory properties of novel anthracyclines in human leukemic cell lines expressing either Pgp-MDR or at-MDR.
Invest New Drugs. 1994;12(2):93-7. doi: 10.1007/BF00874437.